Outlook Therapeutics, Inc. entered into an at-the-market-sales agreement with BTIG, LLC to issue and sell shares of its common stock with an aggregate offering price of up to $100,000,000.
AI Assistant
OUTLOOK THERAPEUTICS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.